GGrantIndex
← Search

Shared Resource: Comparative Medicine

$780,585P30FY2021CANIH

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

PROJECT SUMMARY: COMPARATIVE MEDICINE SHARED RESOURCE (CMSR) The Comparative Medicine Shared Resource (CMSR), located at the Fred Hutch (FH), provides high quality support for preclinical research performed by Consortium investigators. It achieves this through specialized support structures, technology, and personnel expertise. CMSR maintains an AAALAC-accredited, USDA- registered, and PHS-assured facility. CMSR is staffed by three clinical veterinarians with expertise in laboratory animal medicine, animal-use regulations, and facility management and husbandry. An additional 45 personnel provide daily care and treatment to five species of animals currently housed at FH ? mice, rats, dogs, fish, and guinea pigs ? and deliver exceptional husbandry to maintain microbiologic and environmental control of animal colonies. This care encompasses the needs of many specialized animal models of cancer and cancer-related disease states such as transplanted or induced liquid and solid tumors, cancer-related pathogens, graft- versus-host disease, and conditions and treatments related to radiation therapy. The small animal facility is a centralized barrier facility with special areas to accommodate radioactive agents and infectious agents. CMSR specialty services include patient-derived-xenograft (PDX) models and preclinical imaging support in collaboration with the Translational BioImaging Core Shared Resource (TBICSR). A full time veterinary comparative pathologist is available for consultation and collaboration with researchers. Equipment support for CMSR includes individually ventilated micro-isolator rodent cages, a full service rodent cage wash and autoclaves, and numerous surgical-ready procedure rooms for rodent users. Canine support includes specialized housing for Severe Combined Immune Deficiency (SCID) and Pyruvate Kinase (PK) deficient animals, a comprehensive surgical suite and procedure area, and a Linear Accelerator dedicated to preclinical research. CMSR supplies an invaluable, centralized resource to support high quality preclinical studies. Historically, animal models contributed to Nobel Prize winning research in bone marrow transplantation and hematopoietic cancers. The continued expansion of scope and volume of animal-related work now includes solid tumor and cancer-related pathogen research.

View original record on NIH RePORTER →
Shared Resource: Comparative Medicine · GrantIndex